Endocyte

P. Ron Ellis,
CEO / President
Mike A. Sherman,
Chief Financial Officer
Philip S. Low Ph.D,
Chief Science Officer
David Meek,
Chief Commercial Officer
Christopher P. Leamon Ph.D,
Vice President of Research & Development
Chandra D. Lovejoy,
Vice President of Regulatory Affairs
Binh Nguyen M.D., Ph.D.,
Vice President of Clinical Affairs
Allen R. Ritter Ph.D,
Vice President of Manufacturing / CMC
Iontcho Vlahov Ph.D,
Vice President of Discovery Chemistry
Matthew Call,
Vice President of Business Development

John C. Aplin,
Chairman
P. Ron Ellis,
CEO / President
Philip S. Low Ph.D,
Chief Science Officer
Douglas G. Bailey,
President & CEO
American Bailey Corporation
Fred A. Middleton,
General Partner
Sanderling Venture Partners,
Ann F. Hanham Ph.D.
Managing Director
Burrill & Company
Keith E. Brauer,
Former VP Finance / CFO
Guidant Corporation
Peter D. Meldrum Ph.D.,
President & CEO
Myriad Genetics, Inc.
Marc Kozin,
Senior Advisor
L.E.K. Consulting
Lesley Russell M.B.Ch.B, MRCP,
Former Senior Vice President
Teva Pharmaceuticals